Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Sep 8, 2023
- Accession no.
- 0001415889-23-013130
- Filed
- Sep 8, 2023
- Trade date
- Sep 6-7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market sales total $59.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Common Stock | MOption exerciseAcquired | +2,413 | $1.74 | +$4,198.62 | 3,704 | Direct | |
| Sep 6, 2023 | Common Stock | MOption exerciseAcquired | +1,518 | $2.14 | +$3,248.52 | 5,222 | Direct | |
| Sep 6, 2023 | Common Stock | SSaleDisposed | −3,931 | $15.06 | −$59,200.86 | 1,291 | Direct | |
| Sep 7, 2023 | Common Stock | MOption exerciseAcquired | +30 | $2.14 | +$64.2 | 1,321 | Direct | |
| Sep 7, 2023 | Common Stock | SSaleDisposed | −30 | $15.01 | −$450.3 | 1,291 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Common Stock | MOption exerciseDisposed | −906 | $0.00 | $0 | 3,622 | Direct | |
| Sep 6, 2023 | Common Stock | MOption exerciseDisposed | −1,507 | $0.00 | $0 | 16,575 | Direct | |
| Sep 6, 2023 | Common Stock | MOption exerciseDisposed | −1,018 | $0.00 | $0 | 19,350 | Direct | |
| Sep 6, 2023 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 150,256 | Direct | |
| Sep 7, 2023 | Common Stock | MOption exerciseDisposed | −30 | $0.00 | $0 | 150,226 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.